Compare GSK plc (GSK) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Alliant Energy Corporation — how do they compare? GSK plc trades at $52.56 (market cap $101.34B), while Alliant Energy Corporation trades at $75.36 (market cap $19.25B). The key difference: GSK plc is far larger — about 5.3× Alliant Energy Corporation's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | LNT | |
|---|---|---|
Market Cap | $101.34B | $19.25B |
Sector | Health | Utilities |
52-Week High | $61.18 | $78.03 |
52-Week Low | $36.20 | $62.87 |
Enterprise Value | $121.95B | $30.98B |
Dividend Yield | 3.49% | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
LNT trades at $76.31, down 0.42% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $78.50. The company reported Q1 2026 EPS of $0.82, beating estimates, with revenue growth and a net income margin of 18.58%. Recent news highlights a $13.4 billion clean energy investment plan targeting 5-7% annual earnings growth, supported by rising data center demand.
The outlook for LNT is positive, driven by strategic capital investments and regulatory support for utilities. Key opportunities include earnings growth from data center expansion and renewable projects, while risks involve execution of large-scale investments and rising debt levels, with the debt-to-asset ratio increasing to 48.48% in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
